New pain drug HRS-2129 tested in healthy adults
NCT ID NCT06742840
First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This early-stage study tested a new drug called HRS-2129 in 23 healthy adults to see if it is safe and how the body processes it. Participants received multiple doses and had pain tests like cold and heat sensitivity. The goal was to gather safety data and measure how the drug affects pain detection, not to treat any existing pain condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.